Clinical Research Findings on AOD-9604 In clinical trials involving approximately 900 participants across six human studies, AOD-9604 demonstrated a favorable safety and tolerability profile
Consult with a healthcare provider for a personalized recommendation
Key Takeaways Before the FAQ 1
My GP has (eventually) referred me to both a rheumatologist and an endocrinologist for further investigations, so perhaps that will throw some light on the matter
the most common were dry mouth and insomnia. Astrup et al., The Lancet Who Should Avoid Tesofensine Individuals with uncontrolled hypertension or cardiovascular disease Anyone on SSRIs, SNRIs, or MAO inhibitors (risk of serotonin syndrome) Those with a history of severe anxiety, panic disorder, or arrhythmias Pregnant or breastfeeding women (due to lack of safety data) Best Practices for Safety Start at 0.25 mg/day and gradually titrate Avoid stacking with caffeine , yohimbine , or stim-heavy pre-workouts Monitor blood pressure, heart rate, and sleep quality Discontinue use if side effects worsen or persist beyond the adaptation period (710 days) Although Tesofensine has a relatively clean side effect profile at moderate doses, its still a powerful central agent
